TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion - Concepedia

Concepedia

Publication | Open Access

TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion

DOI Full Paper Access

16

Citations

41

References

2024

Year

Anaïs Debesset, Caroline Pilon, Sylvain Meunier, Orianne Cuelenaere-Bonizec, Wilfrid Richer, Allan Thiolat, Claire Houppe, Matteo Ponzo, J Magnan, Jonathan Caron,

Journal for ImmunoTherapy of Cancer

Abstract

Our data suggest that combining a CD40 agonist with a TNFR2 antagonist represents a promising therapeutic strategy for patients with PDAC.

References

	Year	Citations

Page 1